Press Releases


SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For the Three Months of the Fiscal Year, Ending June 30 2014(From July 1, 2013 to September 30, 2013)

(135.6 KB)2013:12:04:10:11:38

PSS and Roche enter into a new Development Agreement concerning emPCR Automation Instrument to be developed by PSS


SUMMARY OF CONSOLIDATED FINANCIAL STATEMENTS For Fiscal Year 2013 (From July 1, 2012 to June 30, 2013)

(145.5 KB)2013:09:03:15:09:28

PSS and LG Life Sciences enter into a Supply and Distribution Agreement for PSS's "geneLEAD", a fully automated, sample-to-result system for NAT


PSS reaches Desalter Development Agreement with Abbott


PSS FY 2013 Third Quarter Financial Statements (Summary)

(137.5 KB)2013:05:29:11:10:31

Termination of Agreement with Roche to develop a Fully Automated Emulsion PCR Instrument for Next-generation Sequencing Platforms


PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's "geneLEAD", a fully automated, sample-to-result, Real-Time PCR analyzer


PSS FY 2013 Second Quarter Financial Statements (Summary)

(148.6 KB)2013:02:26:16:31:43
Press Releases
Back to top of page